Skip to main content
. 2018 Feb 14;6(2):119–126. doi: 10.14218/JCTH.2017.00064

Table 4. Studies evaluating statin use in patients with primary biliary cholangitis.

Author Country Methodology Period Comments Findings
Simvastatin
Del Puppo et al.45 2001 Italy Single-center, prospective study 30 days 6 patients with PBC treated with simvastatin (40 mg daily) Significant reduction in total cholesterol (34% in 30 days)
Cash et al.46 2013 UK Single-blind, randomized control study 1 year 21 patients with PBC received simvastatin (20 mg daily) or matched placebo Significantly lower cholesterol in treatment arm (p = 0.01) but no significant difference in pulse wave velocity (p = 0.66)
Atorvastatin
Stanca et al.47 2008 USA Retrospective study Median 2.5 years 15 patients with PBC treated with atorvastatin compared to age- and sex-matched PBC patients who did not receive statin treatment Significant reduction in cholesterol (p < 0.002)
Stojakovic et al.48 2007 Austria Single-center, prospective study 20 weeks 15 patients with PBC treated with atorvastatin (at 10 mg/day, 20 mg/day and 40 mg/day) for 4 weeks respectively Significant reduction in total cholesterol (35%, p < 0.001)
Stojakovic et al.49 2009 Austria Single-center, prospective study 1 year 19 patients with PBC treated with atorvastatin (10 mg daily) Significant reduction in total cholesterol and improvement in vascular function. No effect on cholestasis progression.